Full datetime event:Wednesday, November 15, 20175:30 pm
The Innevation Center
450 Sinclair St.
DescriptionMichael will discuss how the healthcare environment is undergoing a once-in-a-career transformation, and the opportunities it's creating for technology innovators. Michael will discuss a technology developed to serve this change by Oculeve, Inc., a company which he co-founded and served as its CEO before an acquisition by the drug and device company Allergan, plc.
Don't miss Michael's amazing story of how he overcame seemingly insurmountable roadblocks both physical and financial to get this product funded.
5:30pm - 6:30pm Networking with Beer & Pizza
6:30pm - 6:40pm Member Spotlight
6:40pm - 7:30pm Featured Speaker - Michael Ackermann
7:30pm - 8:00pm Networking with Beer & Pizza
About the Presenter:
Michael currently serves as Chairman of Oyster Point Pharmaceuticals, Inc. and is additionally developing two early-stage healthcare ventures. He was mostly recently Vice President, Neurostimulation for Allergan, plc after serving as CEO of Oculeve, Inc., which was acquired by Allergan in August 2015. He has thirteen years of experience in medical device and pharmaceutical development in both academic and industrial settings. He received a B.E. degree, magna cum laude, in biomedical engineering from Vanderbilt University, M.S. and Ph.D. degrees in biomedical engineering from Case Western Reserve University, is a graduate of the Stanford University Biodesign Fellowship, and Vision Research Fellowship at Stanford. He has
numerous patents and peer-reviewed publications.